DINESH

Bajaj Healthcare

Industry: Healthcare
Latest CMP 329
Today's Change ▼ -0.63%
52-Week High / Low 507 | 275
Price Date: 14-Aug-2026
Recommendation Strong Sell
Target Price 276
Expected Upside -8.4%
Forecast Horizon 2 Years
Historical CAGR Not Available
1,000 Invested
Today's Value
Investment Period < 5 Years

Stock Snapshot

Post Results Return
-1.8%
Neutral Market Reaction
1-Year Target Price
219
2-Year Target Price
276
52-Week High / Low
507 / 275
20-Day Return
-14.8%
Market Cap (Cr.)
981
Current PE
17.9
P/BV Ratio
2.1
Dividend Yield
0.2%
Industry PE
57.2

Price Performance

Basis of our Recommendation

Bajaj Healthcare's recent management commentary and industry dynamics suggest a cautious outlook for revenue growth, primarily due to anticipated revenue contraction over the forecast period. Despite the stable profit margins, the company faces challenges from competitive pressures and a fragmented market, which could hinder its ability to capture market share effectively. Vista's financial outlook reflects these concerns, projecting a slight decline in revenue while maintaining stable margins, supported by a stable balance sheet. The healthcare sector's growth trajectory, driven by increasing demand for organized healthcare services, provides a backdrop for potential long-term growth, although margin pressures remain a significant watchpoint. Over the next 12-24 months, key opportunities include the ongoing shift towards organized healthcare and rising insurance coverage, while headwinds consist of competitive pressures, regulatory challenges, and potential earnings volatility. Overall, while the investment recommendation remains a 'Buy' with a modest expected upside, investors should remain vigilant regarding the evolving market landscape and its impact on Bajaj Healthcare's performance

👍 Why We Like This Stock

  • Stable profit margins despite revenue contraction expectations
  • Ongoing shift towards organized healthcare services presents long-term growth opportunities
  • Stable balance sheet metrics support operational resilience

Things To Watch Out For

  • Anticipated revenue decline due to competitive pressures in a fragmented market
  • Regulatory challenges may impact earnings stability
  • Potential volatility in earnings could affect investor sentiment

Key Parameters

Balance Sheet Strength
Stable Financial Structure
Market Share
Stable
Industry Outlook
Stable
Analyst View
Not Available
Dividend History
Regular
FII Holdings
Stable

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 473 543 611 302 284
Profit Before Tax (Cr.) 28 47 62 48 41
PBT Margin 5.9% 8.6% 1011.3% 15.9% 14.5%
Net Profit (Cr.) -42 43 55 36 31
Earnings Per Share -14.1 14.6 18.5 12.1 10.3

Analyst Recommendations

No analyst recommendations available.

Consensus Recommendation ► None
Consensus Target
Coverage 0 Analysts
Analysts' Viewpoint

Company Overview

Show Company Profile